FDA Rejects Drug for Chronic Cough

(MedPage Today) -- The FDA declined to approve oral gefapixant for treating chronic cough, Merck announced on Wednesday. In its complete response letter, "the FDA concluded that Merck's application did not meet substantial evidence of effectiveness...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news